Loading CL detail
Loading ticker data...
Loading CL detail
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide.
The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers.
Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Chart data unavailable
CL braces for tariff volatility into 2026, leaning on supply-chain shifts, pricing discipline and productivity gains to defend margins.
Cache Advisors LLC bought a new position in Colgate-Palmolive Company (NYSE: CL) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,621 shares of the company's stock, valued at approximately $523,000. Other hedge funds have also added to or reduced their
Allspring Global Investments Holdings LLC reduced its position in Colgate-Palmolive Company (NYSE: CL) by 62.2% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 36,331 shares of the company's stock after selling 59,762 shares during the period. Allspring Global Investments Holdings LLC's holdings in Colgate-Palmolive were
For the second-straight year and third time in five years, the Dow, S&P 500, and Nasdaq started off the calendar with quarterly losses. ‘Didn't get off the bus,' is the apt sports colloquial that comes to mind.
Revolve Wealth Partners LLC lowered its position in shares of Colgate-Palmolive Company (NYSE: CL) by 34.5% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,022 shares of the company's stock after selling 8,452 shares during the quarter. Revolve Wealth Partners LLC's
Ascent Group LLC raised its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 19.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,321 shares of the company's stock after purchasing an additional 5,906 shares during the period.
Braun Stacey Associates Inc. trimmed its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 4.0% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 223,790 shares of the company's stock after selling 9,343 shares during the quarter. Braun Stacey Associates
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Colgate-Palmolive (CL). But which of these two stocks is more attractive to value investors?
CL's Hill's Pet Nutrition outperforms a soft market as prescription diets, cat growth and science-led innovation drove share gains and sustained momentum.
Colgate-Palmolive expects to drive growth in North America this year, in part with new versions of products in oral and skin care.
Brookstone Capital Management raised its stake in Colgate-Palmolive Company (NYSE: CL) by 11.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 158,730 shares of the company's stock after purchasing an additional 15,842 shares during the period. Brookstone Capital
Colgate-Palmolive (NYSE:CL) lost a key Wall Street backer on Tuesday as TD Cowen analyst Robert Moskow downgraded the stock from Buy to Hold and cut his price target to $85 from $96, citing surging oil-based input costs tied to the Iran War.
Colgate-Palmolive's recent decline has the stock squarely in correction territory. The recent 13.6% drop in just a month may be a case of too much too fast.
Pre-Market Stock Futures: Futures are trading higher this morning after reports are circulating that President Trump wants to end the war soon. This comes after Monday's session, which saw three of the four major indices close lower, while oil traded above $100 for the first time since the summer of 2022. Conflicting headlines flew around;... Here Are Tuesday's Top Wall Street Analyst Research Calls: Arista Networks, Block, Colgate-Palmolive, Digital Realty, Emerson Electric, MiniMed, Shake Shack, and More.
The ongoing Iran-Israel-US war, Strait of Hormuz closure, and global economic risks. James Kostohryz explains why disruptions could persist for months.
